Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PIM447

PIM447 (LGH447) is a potent, orally available, and selective pan-PIM kinase inhibitor, with Ki values of 6, 18, and 9 pM for PIM1, PIM2, and PIM3, respectively. PIM447 displays dual antimyeloma and bone-protective effects. PIM447 induces apoptosis[1][2].

Product Specifications

CAS Number

1210608-43-7

Product Name Alternative

LGH447

UNSPSC

12352005

Hazard Statement

H301-H311-H331

Target

Apoptosis; Pim

Type

Reference compound

Related Pathways

Apoptosis; JAK/STAT Signaling

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/PIM447.html

Concentration

10mM

Purity

99.52

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=C(F)C(C2=C(F)C=CC=C2F)=N1)NC3=C([C@@H]4C[C@H](C)C[C@H](N)C4)C=CN=C3

Molecular Formula

C24H23F3N4O

Molecular Weight

440.46

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361-P403+P233-P405-P501

References & Citations

[1]Paíno T et al. The novel pan-PIM kinase inhibitor, PIM447, displays dual anti-myeloma and bone protective effects, and potently synergizes with current standards of care. Clin Cancer Res. 2016 Jul 20.|[2]Peters TL et al. Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.
 Oncotarget. 2016 Aug 20|[3]Burger MT, et al. Identification of N- (4- ((1R,3S,5S) -3-Amino-5-methylcyclohexyl) pyridin-3-yl) -6- (2,6-difluorophenyl) -5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.J Med Chem. 2015 Nov 12;58 (21) :8373-86.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 1

Isoform

PIM1; PIM2; PIM3

Citation 01

BioRxiv. 2024 Mar 28.|bioRxiv. 2024 October 24.|Cell Chem Biol. 2024 Feb 15;31 (2) :326-337.e11.|J Pathol. 2020 Sep;252 (1) :65-76.|Blood Adv. 2024 May 13:bloodadvances.2022008144.|Mol Cancer Ther. 2018 Apr;17 (4) :849-857.|PLoS One. 2024 Nov 1;19 (11) :e0308647.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Ɑ-Butyric Acid-ω-Fmoc Amino PEG
1310000-22-32.1G 1 g

Ɑ-Butyric Acid-ω-Fmoc Amino PEG

Sign In for Pricing
View Details
Microparticle Stabilizer Solution
C1010002 50 mL

Microparticle Stabilizer Solution

Sign In for Pricing
View Details
Human CDKL4 activation kit by CRISPRa
GA117589 1 Kit

Human CDKL4 activation kit by CRISPRa

Sign In for Pricing
View Details
2-Hydroxydecanoic Acid
TRC-H235135-50MG 50 mg

2-Hydroxydecanoic Acid

Sign In for Pricing
View Details
Tissue Total RNA, Colon: sigmoid
CR560687 5 µg

Tissue Total RNA, Colon: sigmoid

Sign In for Pricing
View Details
SUOX Mouse Monoclonal Antibody [Clone ID: OTI1C5]
CF806247 100 µg

SUOX Mouse Monoclonal Antibody [Clone ID: OTI1C5]

Sign In for Pricing
View Details